Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
AO

AORT

Market Closed

Artivion, Inc.

NYSEHealthcareMedical - Devices
US
1.80K employees
CEO: James Patrick Mackin
Founded: 1993
$26.57
+$0.00(+NaN%)
Market Cap
1.29B
Beta
1.25
52W Range
N/A
Dividend Yield
0.45%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Artivion trades 22.6% above its PERT-weighted fair value of $20.25, reflecting overvaluation risk amid low profitability and efficiency scores despite strong growth and liquidity. Conflicting valuations—from negative DCF to $48 analyst targets—increase uncertainty. High downside risk and valuation volatility underscore significant investment risk.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore AORT

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

AORT in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →